Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $38.6 million.

  • Cellebrite DI's Other Operating Expenses rose 854.91% to $38.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $154.6 million, marking a year-over-year increase of 1701.02%. This contributed to the annual value of $154.8 million for FY2025, which is 1713.43% up from last year.
  • Per Cellebrite DI's latest filing, its Other Operating Expenses stood at $38.6 million for Q4 2025, which was up 854.91% from $38.6 million recorded in Q3 2025.
  • Cellebrite DI's Other Operating Expenses' 5-year high stood at $38.8 million during Q1 2025, with a 5-year trough of $16.5 million in Q1 2021.
  • In the last 5 years, Cellebrite DI's Other Operating Expenses had a median value of $27.2 million in 2023 and averaged $28.4 million.
  • Per our database at Business Quant, Cellebrite DI's Other Operating Expenses skyrocketed by 3440.49% in 2022 and then skyrocketed by 646.63% in 2023.
  • Cellebrite DI's Other Operating Expenses (Quarter) stood at $20.1 million in 2021, then increased by 17.32% to $23.5 million in 2022, then grew by 25.52% to $29.5 million in 2023, then increased by 20.25% to $35.5 million in 2024, then rose by 8.55% to $38.6 million in 2025.
  • Its last three reported values are $38.6 million in Q4 2025, $38.6 million for Q3 2025, and $38.7 million during Q2 2025.